Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 796 AL 810

Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment

Loera-Valencia R, Goikolea J, Parrado-Fernandez C, Merino-Serrais P, Maioli S.

J Steroid Biochem Mol Biol. 2019 Jun;190:104-114. doi: 10.1016/j.jsbmb.2019.03.003. Epub 2019 Mar 13.

The - weak - role of memory in tool use: Evidence from neurodegenerative diseases

Baumard J, Lesourd M, Remigereau C, Merck C, Jarry C, Etcharry-Bouyx F, Chauviré V, Belliard S, Moreaud O, Osiurak F, Le Gall D.

Neuropsychologia. 2019 Jun;129:117-132. doi: 10.1016/j.neuropsychologia.2019.03.008. Epub 2019 Mar 19.

Polygenic risk and hazard scores for Alzheimer's disease prediction

Leonenko G, Sims R, Shoai M, Frizzati A, Bossù P, Spalletta G, Fox NC, Williams J; GERAD consortium; Hardy J, Escott-Price V.

Ann Clin Transl Neurol. 2019 Feb 18;6(3):456-465. doi: 10.1002/acn3.716. eCollection 2019 Mar.

Metabolic Syndrome, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Longitudinal Studies

Atti AR, Valente S, Iodice A, Caramella I, Ferrari B, Albert U, Mandelli L, De Ronchi D.

Am J Geriatr Psychiatry. 2019 Jun;27(6):625-637. doi: 10.1016/j.jagp.2019.01.214. Epub 2019 Feb 15.

A Review on the Trajectory of Attentional Mechanisms in Aging and the Alzheimer's Disease Continuum through the Attention Network Test

McDonough IM, Wood MM, Miller WS Jr.

Yale J Biol Med. 2019 Mar 25;92(1):37-51. eCollection 2019 Mar.

Physical Activity Alleviates Cognitive Dysfunction of Alzheimer's Disease through Regulating the mTOR Signaling Pathway

Kou X, Chen D, Chen N.

Int J Mol Sci. 2019 Mar 29;20(7):1591. doi: 10.3390/ijms20071591.

Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia

Rabinovici GD, Gatsonis C, Apgar C, Chaudhary K, Gareen I, Hanna L, Hendrix J, Hillner BE, Olson C, Lesman-Segev OH, Romanoff J, Siegel BA, Whitmer RA, Carrillo MC.

JAMA. 2019 Apr 2;321(13):1286-1294. doi: 10.1001/jama.2019.2000.

Diet and Inflammation in Cognitive Ageing and Alzheimer's Disease

McGrattan AM, McGuinness B, McKinley MC, Kee F, Passmore P, Woodside JV, McEvoy CT.

Curr Nutr Rep. 2019 Jun;8(2):53-65. doi: 10.1007/s13668-019-0271-4.

An urgent need to assess safe levels of inorganic copper in nutritional supplements/parenteral nutrition for subset of Alzheimer's disease patients

Kumar A, Sharma P, Prasad R, Pal A.

Neurotoxicology. 2019 Jul;73:168-174. doi: 10.1016/j.neuro.2019.04.001. Epub 2019 Apr 4.

APOE ɛ4 and REM Sleep Behavior Disorder as Risk Factors for Sundown Syndrome in Alzheimer's Disease

Pyun JM, Kang MJ, Yun Y, Park YH, Kim S.

J Alzheimers Dis. 2019;69(2):521-528. doi: 10.3233/JAD-190032.

APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer's disease pathophysiology

Tran TTT, Corsini S, Kellingray L, Hegarty C, Le Gall G, Narbad A, Müller M, Tejera N, O'Toole PW, Minihane AM, Vauzour D.

FASEB J. 2019 Jul;33(7):8221-8231. doi: 10.1096/fj.201900071R. Epub 2019 Apr 8.

Efficacy and Limitations of rCBF-SPECT in the Diagnosis of Alzheimer's Disease With Amyloid-PET

Takahashi M, Tada T, Nakamura T, Koyama K, Momose T.

Am J Alzheimers Dis Other Demen. 2019 Aug;34(5):314-321. doi: 10.1177/1533317519841192. Epub 2019 Apr 9.

Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease

Egan MF, Kost J, Voss T, Mukai Y, Aisen PS, Cummings JL, Tariot PN, Vellas B, van Dyck CH, Boada M, Zhang Y, Li W, Furtek C, Mahoney E, Harper Mozley L, Mo Y, Sur C, Michelson D.

N Engl J Med. 2019 Apr 11;380(15):1408-1420. doi: 10.1056/NEJMoa1812840.

The new genetic landscape of Alzheimer's disease: from amyloid cascade to genetically driven synaptic failure hypothesis?

Dourlen P, Kilinc D, Malmanche N, Chapuis J, Lambert JC.

Acta Neuropathol. 2019 Aug;138(2):221-236. doi: 10.1007/s00401-019-02004-0. Epub 2019 Apr 13.

The Limitations of Using Cognitive Cutoff Scores for Enrollment in Alzheimer Trials

Patrick RE, Hobbs K, Mathias L, Harper DG, Forester BP.

Am J Geriatr Psychiatry. 2019 Oct;27(10):1153-1158. doi: 10.1016/j.jagp.2019.02.014. Epub 2019 Mar 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias